Sat.Jul 25, 2020 - Fri.Jul 31, 2020

article thumbnail

Merck nears clinical tests for coronavirus vaccine candidates

Bio Pharma Dive

Two candidates recently acquired in deals with IAVI and Themis have shown promise in preclinical studies, Merck executives said, and Phase 1 trials will begin later this year.

article thumbnail

Ten pharma digital marketing facts

World of DTC Marketing

QUICK READ: A reporter for a leading business magazine recently reached out to me and asked “what are Pharma product websites so bad?” OK, maybe not all of them are that bad but I would bet that 80% are really poor. There is a lot of blame to go around but these facts are still relevant today. 1ne: There is a direct correlation between time on site and asking for/about your product.

Marketing 183
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Preclinical and Nonclinical Studies— What Is the Difference, and Where in Your Program Should They Fall?

Camargo

Have you ever wondered about the difference between preclinical and nonclinical studies? While those in. The post Preclinical and Nonclinical Studies— What Is the Difference, and Where in Your Program Should They Fall? appeared first on Camargo.

149
149
article thumbnail

Pharmapack Moves to May 2021

Pharma Mirror

Pharmapack Europe (#pharmapackeu), organised by Informa Markets, moves to May 2021 (19-20) to provide attendees, exhibitors and the pharma packaging community the best season and format. The decision follows a careful review with key stakeholders, with the exhibition continuing at its usual location: Hall 7.2 at Paris Expo, Porte de Versailles. By announcing the rescheduling.

article thumbnail

From Diagnosis to Delivery: How AI is Revolutionizing the Patient Experience

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

article thumbnail

Vaccine sales driven down by pandemic's effects on doctor visits

Bio Pharma Dive

Pfizer, Sanofi, GSK and Merck each reported lower vaccine sales as stay-at-home orders kept people from their regular vaccinations.

Sales 237
article thumbnail

COVID 19 vaccine means big money and greed

World of DTC Marketing

QUICK READ : Pharma had a chance to earn some goodwill with a very skeptical public but it’s become obvious that the rush to develop a vaccine is about profit, executive stock, and Wall Street despite potential huge investments from the government. Moderna, which has received a ton of money from the government, told lawmakers it would not sell its vaccine at cost.

More Trending

article thumbnail

Softbox announces the appointment of new global CFO

Pharma Mirror

Softbox, a leading global innovator and provider of temperature control packaging systems and thermal covers for the life science and logistics industries, has announced the appointment of Charlie Nicholson as Softbox’s new Global CFO. Reporting directly to Kevin Valentine, CEO of Softbox, Charlie Nicholson joins the leadership team and is responsible for all financial and.

article thumbnail

Survey: Gen Z’ers Want to Eat More Plant-Based and Vegan Foods

XTalks

Gen Z is setting food trends in the post-pandemic world, The Food Institute reports, and their food choices include: Ordering in more, choosing frozen foods and eating more plant-based meals. They believe you don’t have to be vegan to want to eat more vegan foods, the Institute report noted, in a review of how these young consumers are influencing food trends.

Protein 116
article thumbnail

Lonza: the right bio model can make a difference

Outsourcing Pharma

A leader from the health solutions and technology company explains how the proper biological models can enhance drug discovery and development.

article thumbnail

MHRA OKs Celltrion's Phase I trial of COVID drug

Pharma Times

The trial will enrol patients with mild symptoms of SARS-CoV-2 infection to evaluate the safety, tolerability, efficacy, pharmacokinetics and immunogenicity of CT-P59

Trials 112
article thumbnail

Optimizing Clinical Supply Strategy: Navigating Challenges & Finding Your Ideal Model

article thumbnail

Made-in-Singapore Cancer Drug ETC-159 Advances Further in Clinical Trials

Pharma Mirror

First dose of ETC-159 administered in Phase 1B of clinical trials, advancing the development of this drug to treat solid tumours Made-in-Singapore cancer drug, ETC-159, has achieved a new developmental milestone in achieving “First Patient First Visit[1]” in Phase 1B. The first dose of ETC-159 has been administered to patients in this new phase of.

article thumbnail

Could Soil-Free Farming Prevent Future Food Insecurity?

XTalks

Soil-free, computer-controlled farms could offer a solution for future crop growing as climate change and soil erosion limit farmers’ ability to grow, according to new research. The research , published in New Phytologist and led by scientists at the University of Bristol, John Innes Centre and LettUs Grow, describe the growing environmental and economic case for vertical farming methods which could see crops grown in previously unfarmable environments such as the deserts of Dubai to count

Research 105
article thumbnail

Kodak C.E.O. Got Stock Options Day Before News of Loan Sent Stock Soaring

NY Times

The stock options suddenly were worth about $50 million — the latest instance of extraordinary good timing by corporate executives.

98
article thumbnail

EU regulators approve Novartis' breast cancer combo

Pharma Times

Piqray in combination with fulvestrant is the first treatment for tumours with a PIK3CA mutation

article thumbnail

The New Age of Decentralized Clinical Trials

White paper that delves into the complex topic of Decentralized Clinical Trials and how to master them within the confines of FDA Regulations

article thumbnail

How to Know If your Toddler Has Tooth Decay and How to Reverse It?

Pharma Mirror

What is a toddler tooth decay? Do you have children in your house? Then you must face the problem of dental cavities and tooth decay and have to deal with these as well. Usually, the decay of the tooth is a breakdown or destruction of tooth enamel. We all know the fact that enamel is. The post How to Know If your Toddler Has Tooth Decay and How to Reverse It?

130
130
article thumbnail

Are All Excipients Truly Inert? Maybe Not, Suggests New Study

XTalks

For decades, formulation scientists have relied on the assumption that common pharmaceutical excipients are biologically inert. Now, results from a new study conducted by researchers at the UC San Francisco (UCSF) School of Pharmacy and the Novartis Institutes for BioMedical Research (NIBR), have challenged drugmakers’ understanding of the effects of excipients.

Protein 103
article thumbnail

6 Key Takeaways from HBA’s “Virtual Best Practices: Clarity, Collaboration and Connecting”

Pharma Marketing Network

Recently, the Healthcare Businesswomen’s Association (HBA) held a webinar entitled, Virtual Best Practices: Clarity, Collaboration and Connecting , which dove into the topic of “Zoom fatigue,” a new, commonly used term defined by the draining feeling you experience after a day of long, unnecessary meetings. We are all facing new challenges in the rapidly changing work environment.

article thumbnail

Corporate Insiders Pocket $1 Billion in Rush for Coronavirus Vaccine

NY Times

Well-timed stock bets have generated big profits for senior executives and board members at companies developing vaccines and treatments.

article thumbnail

How Machine Learning Drives Clinical Trial Efficiency

Clinical trial data management is increasingly challenging as studies grow in complexity. Quickly accessing and analyzing study data is vital for assessing trial progress and patient safety. In this paper, we explore real-time data access and analysis for proactive study management. We investigate using adverse event (AE) data to monitor safety and discuss a clinical analytics platform that supports collaboration and data review workflows.

article thumbnail

PCRS releases new guidance on diagnosis of respiratory conditions during COVID

Pharma Mirror

The Primary Care Respiratory Society (PCRS) has issued a position statement and recommendations for clinicians on the diagnostic work up of patients presenting with respiratory symptoms while Covid-19 remains in active circulation. The recommendations bring together the cross-functional experience of PCRS members on the safest and most appropriate approach when evaluating patients presenting with respiratory.

130
130
article thumbnail

Good Gut Bacteria Can Aid in Healing Intestines Damaged by IBD

XTalks

A study published in Nature on July 30, 2020 states that good bacteria living in our gut can do much more than just help digest food and boost our immune system. According to studies conducted by researchers at Cincinnati Children’s Hospital, the bacteria can help heal damaged intestinal tissues. The findings show that the bacteria in the intestine can help repair tissue damage among patients with inflammatory bowel diseases, including Crohn’s disease and ulcerative colitis.

article thumbnail

Ensuring process consistency and cost effectiveness with AIM 3000

Syntegon Technology Pharma Blog

96
article thumbnail

Parexel: improving trial diversity can elevate outcomes

Outsourcing Pharma

A representative from the pharma services firm discusses how increasing diversity of clinical trial populations can improve research effectiveness.

Trials 94
article thumbnail

What the FDA's New Dosage Guidance Means for the Future of Clinical Research

Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist

What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.

article thumbnail

CPhI Japan rescheduled for Spring 2021 with digital solutions to be launched

Pharma Mirror

CPhI Japan – organised by Informa Markets – announces that, following a detailed review with partners and key industry stakeholders and to ensure the health and safety of our community, the event will be postponed until April 14-16, 2021. The event organiser’s move to the new dates will provide more time for the market to. The post CPhI Japan rescheduled for Spring 2021 with digital solutions to be launched appeared first on Pharma Mirror Magazine.

Marketing 130
article thumbnail

Dunkin’ and Bark Bringing Joy to Children

XTalks

Starting next week, Dunkin’ and Bark are collaborating to create a new Dunkin’ inspired plush dog toy being sold in restaurants nationwide. Proceeds are going to the Dunkin’ Joy in Childhood Foundation. The Dunkin’ Joy in Childhood Foundation and Bark are creating dog toys in the shape of Munchkins donut holes and hot coffee cups. The toys will be available at the beginning of August and will be sold in participating restaurants while supplies last.

article thumbnail

A Possible Weapon Against the Pandemic: Printing Human Tissue

NY Times

Bioprinting could be used for testing potential treatments for Covid-19, cancer and other diseases.

84
article thumbnail

Kodak Pharmaceuticals lands $765m US loan

Outsourcing Pharma

The imaging companyâs newly launched division, created to produce drug ingredients, received the loan from the US International Development Finance Corp.

article thumbnail

European Clinical Supply Planning: Balancing Cost, Flexibility and Time

article thumbnail

Impact Biomedical initiates Quantum Research Program to solve the Patent Cliff

Pharma Mirror

SGX-listed Singapore eDevelopment Limited’s (SeD; SGX:40V) wholly-owned subsidiary Impact Biomedical Inc. (“Impact”), announced today the initiation of Quantum, their research program designed to solve the impending pharmaceutical patent cliff threat. Impact Biomedical’s transition to the Quantum research program comes on the heels of the completion of the research and development stage of its existing biodefense.

Research 130
article thumbnail

Increasing the Business Value of Your HR Data: Integrate to Innovate

XTalks

HR organizations rely on access to employee data to address regulatory requirements, support modernization projects, manage talent, and address mergers and acquisitions. However, the typical HR department has more than nine systems of record and over four hundred data elements per employee, causing many organizations to struggle to find the information they need to meet their HR business objectives.

HR 87
article thumbnail

US expands scope of Janssen's Stelara

Pharma Times

The new approval cover paediatric patients with plaque psoriasis

81
article thumbnail

Risk Score for Development of Critical Illness in Patients With COVID-19

JAMA Internal Medicine

This cohort study examines the characteristics of patients admitted to the hospital with COVID-19 who will need admission to an intensive care unit, mechanical ventilation, or will die, and develops a COVID-19 risk score to predict outcomes.

article thumbnail

The New Age of Decentralized Clinical Trials

This new white paper defines and details the impact of Decentralized Clinical Trials on the Pharmaceutical industry and how the impact can be measured along with steps companies can take to ensure adoption.